PROFUSA, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PROFUSA, INC. (PFSA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $203.71 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-02-26
- PROFUSA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $203.71K, a 9.21% decline from fiscal 2022.
- PROFUSA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $224.38K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2023-12-31 | $203.71K 10-K · filed 2024-02-26 |
| 2022-12-31 | $224.38K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |